Stifel Starts Disc Medicine (IRON) at Buy; 'Positive Into Near-Term Bitopertin Data'
Tweet Send to a Friend
(Updated - April 21, 2023 9:18 AM EDT)
Stifel analyst Ben Burnett initiates coverage on Disc Medicine (NASDAQ: IRON) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Ben Burnett initiates coverage on Disc Medicine (NASDAQ: IRON) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
